Epic™ Vascular H74939200088020Recalls & reported problems
Boston Scientific Corporation · Self-Expanding Stent System · Class 3
All models of Epic Vascular (50)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 10
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 10 adverse event reports that list this exact device (DI 08714729805724), received between Apr 26, 2017 and Jun 27, 2024 — classified as 2 injuries, 8 malfunctions.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Activation, Positioning or Separation Problem4
- Material Deformation2
- Bent1
- Device Damaged Prior to Use1
- Difficult to Advance1
- Entrapment of Device1
- Positioning Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- No Consequences Or Impact To Patient4
- No Code Available1
- No Patient Involvement1
Recent adverse event reports
The 10 most recent of 10 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 27, 2024Material Deformation; Material Deformation
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE STENOSED TARGET LESION WAS LOCATED IN THE ILIAC ARTERY. AN 8X80X120 EPIC VASCULAR SELF-EXPANDING STENT WAS SELECTED FOR TREATMENT. DURING UNPACKING, IT WAS NOTED THAT THE STENT HAS SIGNIFICANT CREASES. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO COMPLICATIONS WERE REPORTED, AND THE PATIENT WAS STABLE POST PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19629491 ↗MalfunctionAug 8, 2023Material Deformation; Material Deformation
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. A 8 X 80 X 120 EPIC VASCULAR STENT WAS SELECTED FOR USE. HOWEVER, AFTER UNPACKING, IT WAS NOTICED THAT THERE WAS A SPACE AT THE TIP OF THE STENT. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AND THE PATIENT STATUS WAS STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17482572 ↗MalfunctionJun 1, 2023Difficult to Advance; Difficult to Advance
REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON (B)(6) 2023. IT WAS REPORTED THAT TRACKING DIFFICULTIES WERE ENCOUNTERED. VASCULAR ACCESS WAS OBTAINED VIA THE RIGHT FEMORAL ARTERY. THE 80% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND SEVERELY CALCIFIED LEFT FEMORAL ARTERY. AFTER A 6F NON-BOSTON SCIENTIFIC (BSC) GUIDE CATHETER WAS PLACED AND A 0.035 AMPLATZ GUIDEWIRE WAS CROSSED THE LESION, AN 8X80X120 EPIC VASCULAR STENT WAS ADVANCED FOR TREATMENT. HOWEVER, THE TIP OF THE STENT COULD NOT CROSS ABOUT 9CM INTO THE END OF THE GUIDEWIRE. THE PROBLEM STILL OCCURRED EVEN AFTER THE PHYSICIAN REPLACED THE GUIDEWIRE. THE DEVICE WAS REMOVED, AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED, AND THE PATIENT STATUS WAS STABLE. HOWEVER, RETURNED DEVICE ANALYSIS REVEALED A STENT PARTIAL DEPLOYMENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17039101 ↗MalfunctionOct 31, 2022Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem
IT WAS REPORTED THAT STENT PARTIAL DEPLOYMENT OCCURRED. THE PATIENT PRESENTED WITH THORACIC AORTIC ANEURYSM AND UNDERWENT TRANSCATHETER AORTIC VALVE REPLACEMENT (TVAR). A 8X80X120 EPIC VASCULAR STENT WAS ADVANCED OVER A 0.014 INCH GUIDEWIRE. HOWEVER, DURING DEPLOYMENT, ONLY A PART OF THE STENT WAS DEPLOYED DESPITE MULTIPLE ATTEMPTS. THE STENT WAS REMOVED WITH THE DELIVERY SYSTEM AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15703843 ↗MalfunctionApr 5, 2021Entrapment of Device; Entrapment of Device
IT WAS REPORTED THAT DEVICE ENTRAPMENT OCCURRED. THE 99% STENOSED TARGET LESION WAS LOCATED IN THE SEVERELY TORTUOUS AND SEVERELY CALCIFIED RIGHT ILIAC ARTERY. FOLLOWING PRE-DILATATION, A 8X80X120 EPIC VASCULAR STENT WAS ADVANCED OVER A NON-BSC GUIDEWIRE. HOWEVER, UPON REMOVAL, THE STENT DELIVERY SYSTEM WAS STUCK ON THE GUIDEWIRE AND COULD NOT BE PULLED OUT SO THE DELIVERY SYSTEM WAS REMOVED TOGETHER WITH THE GUIDEWIRE. NO PATIENT COMPLICATIONS NOR INJURIES WERE REPORTED AND THE PATIENT CONDITION WAS GOOD.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11616311 ↗InjuryNov 5, 2019Positioning Problem; Positioning Problem
IT WAS REPORTED THAT STENT POSITIONING DIFFICULTY WAS ENCOUNTERED. AN 8X80X120 EPIC VASCULAR STENT WAS ADVANCED FOR TREATMENT. HOWEVER, DURING DEPLOYMENT OF THE STENT, THE STENT JUMP SIGNIFICANTLY AND MISSED THE MARK WHERE IT WAS SUPPOSEDLY BE PLACED. THE PROCEDURE WAS COMPLETED WITH AN ADDITIONAL STENT. THERE WERE NO PATIENT COMPLICATIONS NOR INJURIES REPORTED AND THE PATIENT WAS FINE. IT WAS FURTHER REPORTED THAT THE 80% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND MODERATELY CALCIFIED RIGHT COMMON ILIAC ARTERY.
Patient problems: No Code Available; No Consequences Or Impact To Patient
MAUDE report 9280658 ↗MalfunctionJun 26, 2018Bent; Bent
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE TARGET LESION WAS LOCATED IN THE LOWER EXTREMITY ARTERY. AN 8X80X120 EPIC¿ VASCULAR STENT WAS ADVANCED BUT FAILED TO CROSS THE LESION. WHEN THE DEVICE WAS WITHDRAWN, IT WAS NOTED THAT THE STENT STRUTS WERE LIFTED. THE PROCEDURE WAS NOT COMPLETED AS PER PATIENT'S REQUEST. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7638089 ↗InjuryMay 22, 2017Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem
IT WAS REPORTED THE STENT WAS THE WRONG SIZE. THE TARGET LESION WAS LOCATED IN AN 85% STENOSED AND SEVERELY TOURTOUS LEFT LEG ILIAC ARTERY. A CONTRALATERAL APPROACH WAS USED TO ACCESS THE PRE-DILATED LESION. A 6F NON BSC SHEATH AND A 5F NON BSC GUIDE CATHETER WERE ADVANCED. THE TARGET LESION WAS THEN SUBSEQUENTLY TREATED WITH AN EPIC¿ VASCULAR 8X80X120MM STENT. DURING DEPLOYMENT THE STENT DEPLOYED THE FIRST 2CM NORMAL. HOWEVER, THE PHYSICIAN FOUND THE REST OF LENGTH OF DEPLOYED STENT WAS SHORTER THAN EXPECTED. THE DEPLOYED STENT WAS NO MORE THAN 5 CM LONG AND THE LESION WAS NOT FULLY COVERED. THE PHYSICIAN THEN SELECTED A 8X10MM NON BSC STENT TO COVER THE REMAINDER OF THE LESION. THE PROCEDURE WAS COMPLETED BY POST-DILATING THE STENT WITH A MUSTANG BALLOON CATHETER. THE PATIENT WAS STABLE WITHOUT ANY COMPLICATIONS.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6582745 ↗MalfunctionMay 21, 2017Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem
IT WAS REPORTED THAT THE STENT WAS PROTRUDING. AN EPIC¿ VASCULAR STENT 8X80X120 WAS SELECTED FOR A PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) PROCEDURE IN THE ILIAC VEIN FOR A MODERATELY CALCIFIED LESION WITH 99% STENOSIS. DURING UNPACKING, IT WAS NOTED THAT THE STENT WAS PROTRUDING FROM THE SHEATH.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6580775 ↗MalfunctionApr 26, 2017Device Damaged Prior to Use; Activation, Positioning or Separation Problem; Device Damaged Prior to Use; Activation, Positioning or Separation Problem
IT WAS REPORTED THAT INADVERTENT STENT DEPLOYMENT OCCURRED. A 8X80X120 EPIC¿ VASCULAR STENT WAS SELECTED TO TREAT THE LESION. HOWEVER, DURING PREPARATION AND UPON FLUSHING, THE PHYSICIAN NOTED THAT THE DISTAL STENT STRUTS WAS EXPOSED. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Patient Involvement
MAUDE report 6522459 ↗
Other STENT, ILIAC devices
- Cordis S.M.A.R.T. Control Vascular Stent System C10040MLCordis US Corp. · STENT, ILIAC1 recall3 reports
- Absolute Pro 1012534-100Abbott Vascular Inc. · STENT, ILIAC51 reports
- Cordis S.M.A.R.T. Control Vascular Stent System C09060MLCordis US Corp. · STENT, ILIAC1 recall0 reports
- Protégé™ GPS™ SERB65-09-60-80Ev3, Inc · STENT, ILIAC1 recall0 reports
- Absolute Pro 1012535-100Abbott Vascular Inc. · STENT, ILIAC1 death41 reports
- Omnilink Elite 1012631-39Abbott Vascular Inc. · STENT, ILIAC27 reports
- Omnilink Elite 1012632-29Abbott Vascular Inc. · STENT, ILIAC25 reports
- Omnilink Elite 1012631-59Abbott Vascular Inc. · STENT, ILIAC21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page